Stockreport

BioScrip Comments on Implementation of Medicare Home Infusion Transition Benefit

BioPlus Acquisition Corp.  (BIOS) 
Last bioplus acquisition corp. earnings: 11/6 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: bioscrip.com/investors
PDF -- Reaffirming Guidance for 2019 Adjusted EBITDA of at least $75 million -- DENVER, Nov. 01, 2018 (GLOBE NEWSWIRE) --  BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or th [Read more]